J Biol Chem, Vol. 274, Issue 40, 28459-28465, October 1, 1999
Thioredoxin Deficiency Causes the Constitutive Activation of
Yap1, an AP-1-like Transcription Factor in Saccharomyces
cerevisiae*
Shingo
Izawa,
Keiko
Maeda,
Kei-ichi
Sugiyama,
Jun'ichi
Mano,
Yoshiharu
Inoue
, and
Akira
Kimura
From the Department of Molecular Breeding of Microorganisms,
Research Institute for Food Science, Kyoto University, Uji,
Kyoto 611-0011, Japan
 |
ABSTRACT |
Yap1 is a transcription factor that responds to
oxidative stress in Saccharomyces cerevisiae. The activity
of Yap1 is regulated at the level of its intracellular localization,
and a cysteine-rich domain at the C terminus of Yap1 is involved in
this regulation. We investigated the effects of redox-regulatory
proteins, thioredoxin and glutaredoxin, on the regulation of Yap1,
using the deficient mutants of these thiol-disulfide oxidoreductases.
In the thioredoxin-deficient mutant
(trx1
/trx2
), Yap1 was constitutively
concentrated in the nucleus and the level of expression of the Yap1
target genes was high under normal conditions, while this was not the
case for the glutaredoxin-deficient mutant
(grx1
/grx2
). No distinct difference was
observed in the levels of Yap1 protein between the wild type and
trx1
/trx2
. The constitutive activation of Yap1 in trx
/trx2
was observed under
aerobic conditions but not under anaerobic conditions. These findings
suggest that thioredoxin has negative effects on this regulation via
the redox states. We also show the synthetic lethality between
yap1
and trx1
/trx2
mutation, but the
yap1
/grx1
/grx2
triple
mutant was viable, suggesting a difference of the functions between
thioredoxin and glutaredoxin and a genetic interaction between Yap1 and
thioredoxin in vivo.
 |
INTRODUCTION |
Many aerobic organisms show adaptive responses to oxidative stress
by increasing the levels of antioxidant enzymes. A portion of the
adaptive response is regulated at the transcriptional level, and
several transcription factors that regulate the expression of
antioxidant genes have been reported. In Escherichia coli, OxyR, SoxR, and SoxS are key transcription factors for the adaptive response to oxidative stress. OxyR regulates the expression of genes
encoding H2O2-inducible proteins, and SoxR and
SoxS regulate the expression of genes encoding superoxide-inducible
proteins (1). In mammals, two transcription factors, NF-
B and AP-1, have been strongly implicated in the oxidative stress response (2). The
activities of these transcription factors are reversibly controlled
through redox states and modulated by thiol-disulfide oxidoreductases
such as thioredoxin (TRX)1
and glutaredoxin (GRX) (2, 3). OxyR is activated through the formation
of a disulfide bond between Cys199 and Cys208,
and deactivated by the enzymatic reduction of the bond with GRX (3).
The activities of NF-
B and AP-1 are also regulated by the redox
modification of cysteine residues. After the dissociation of
NF-
B/I
B complex, TRX augments the DNA binding and transcriptional activities of NF-
B by reducing the Cys62 residue in its
DNA-binding loop (4-6). Similarly, redox modification of AP-1 is
regulated by a nuclear redox factor, Ref-1, and the Ref-1 activity is
also modulated by TRX (7, 8). TRX can associate directly with Ref-1 in
the nucleus (9, 10).
The contribution of TRX and GRX toward the maintenance of the
intracellular environments in reduced states is comparable to glutathione (11, 12). These thiol-disulfide oxidoreductases may
participate in the control of redox-regulated transcription factors via
the intracellular redox states (3, 13).
Yap1 (yeast AP-1) is a transcription factor crucial for oxidative
stress response in Saccharomyces cerevisiae, and it
regulates the expression of several genes whose gene products play
major roles in the oxidative stress tolerance. The null mutant of the YAP1 gene displayed hypersensitivity to oxidative stress,
and the overexpression of the YAP1 gene confers stress
resistance (14-18). Several target genes for Yap1 have been
identified, such as GSH1 encoding
-glutamylcysteine
synthetase (19), GLR1 encoding glutathione reductase (20),
TRX2 encoding TRX (21), and TRR1 encoding
thioredoxin reductase (22). These gene products are involved in the
adaptive response to oxidative stress.
Yap1 was originally identified as a functional homologue of mammalian
AP-1 on the basis of its ability to bind to an AP-1 recognition element
(23). Yap1 binds to the Yap1 recognition element (YRE:
5'-TTAGT(C/A)A-3') in the promoter region of target genes (24). The N
terminus of Yap1 contains a bZip domain, which is conserved among the
AP-1 family, including mammalian Jun, Fos, and S. cerevisiae
Gcn4 (23). A cysteine-rich domain (CRD) at the C terminus of Yap1,
containing three Cys-Ser-Glu sequence motifs, plays an important role
in the control of Yap1, especially for the intracellular localization
of Yap1 (25, 26). In the response to oxidative stress, the localization
of Yap1 changes dramatically, while the increase in the DNA binding
activity is modest and the levels of Yap1 do not increase (26-28).
Yap1 exists both in the cytoplasm and the nucleus under non-stressed
conditions, while it is concentrated in the nucleus under oxidative
conditions (26). Recently, it has been reported that the localization
of Yap1 is controlled by Crm1-mediated nuclear export and that Yap1 has
an nuclear export sequence (NES) embedded within the CRD (29, 30).
Mutational analysis suggested that cysteine residues within the CRD
serve as redox sensors, which regulate the availability of the NES
(30). Therefore, removal of the CRD causes constitutive accumulation of
Yap1 in the nucleus, which results in the increase of transcription of
the Yap1 target genes (26). Additionally, the CRD is required for Yap1
to discriminate the stresses elicited by H2O2,
diamide, and CdCl2 (27, 28).
The importance of the CRD raised the possibility that TRX and/or GRX
modulate the activity of Yap1 by the redox modification of cysteine
residues, like OxyR, NF-
B, and AP-1. To examine whether TRX and/or
GRX attend the redox regulation of Yap1, we analyzed the phenotypes of
the TRX- and GRX-deficient mutants with respect to the Yap1-mediated
gene expression and the localization of Yap1. Here we show that TRX
deficiency (trx1
/trx2
) caused the
constitutive activation of Yap1 under aerobic conditions but not under
anaerobic conditions, and that GRX deficiency
(grx1
/grx2
) did not affect the Yap1
activity. We also provide the evidence that the
yap1
/trx1
/trx2
triple mutant
shows the synthetic lethality while the
yap1
/grx1
/grx2
triple mutant
was viable.
 |
EXPERIMENTAL PROCEDURES |
Yeast Strains and Medium--
S. cerevisiae YPH250
and YPH252 were obtained from the Yeast Genetic Stock Center,
University of California, Berkeley, CA. Cells were cultured in 50 ml of
SD minimal medium (2% glucose, 0.67% yeast nitrogen base without
amino acids, pH 5.5) with appropriate amino acids and bases at 30 °C
with reciprocal shaking in 200-ml Erlenmeyer flasks. For anaerobic
cultivation, the medium was flushed with nitrogen gas, sealed up, and
incubated without shaking at 30 °C. Exponentially growing cells were
harvested at A610 = 0.5.
Construction of TRX- and GRX-deficient Mutants--
The
yap1
mutants were constructed by using pSM27 as described
by Wu et al. (17). pSM27 was digested with EcoRI
and transformed to YPH250 (MATa
trp-
1 his3-
200 lys2-801
leu2-
1 ade2-101 ura3-52) and YPH252
(MAT
trp-
1 his3-
200
lys2-801 leu2-
1 ade2-101 ura3-52) to yield the
yap1
and YA-1
, respectively. All mutants used in this
study were derived from YPH250 except for YA-1
and YT-1
(see below).
S. cerevisiae has two cytosolic TRX genes, TRX1
and TRX2 (31); one mitochondrial TRX gene, TRX3
(32); and two GRX genes, GRX1 and GRX2
(TTR1) (33, 34). To disrupt the TRX1 gene, the TRX1 gene was amplified using the following
oligonucleotide primers: 5'-GATCAGAATGATTGAAATCA-3' and
5'-GACGAGCTATAGGATGATGA-3'. The amplicon (2.0 kb) was treated by Klenow
fragment, and then cloned, respectively, to the HincII site
of pUC19 (pTR-1) and to the BamHI site of YEp13, which was
also treated by Klenow fragment (YEpTRX1). The URA3 gene
(1.2 kb) isolated from YEp24 was treated with Klenow fragment and
inserted between the MunI/MunI sites internal to the TRX1 gene in pTR-1, which was also treated by Klenow
fragment, to yield pTRD1. pTRD1 was digested with ApaLI and
DraI, and the trx1
::URA3
fragment was transformed to YPH250 and YA-1
to yield the
trx1
and YT-1
, respectively. Disruption of the
TRX2 gene was done using the
trx2::HIS3 disruption plasmid, kindly
provided by Drs. S. Kuge and N. Jones (21). The
trx2::HIS3 disruption plasmid was
digested with SphI, and the
trx2
::HIS3 fragment was transformed
to YPH250 and the trx1
mutant to yield the
trx2
mutant and the trx1
/trx2
mutant, respectively. Additionally, the
trx2::LEU2 disruption plasmid was
constructed. The TRX2 gene was amplified by using the
following oligonucleotide primers: 5'-GATCAGCATAACTTGAGTGC-3' and
5'-GATCGCATGGAACGCCAAGC-3'. The amplicon (0.8 kb) was treated
with Klenow fragment, and then cloned to the HincII site of
pUC19 (pTR-2), and to the BamHI site of YEp13 (YEpTRX2),
respectively. The LEU2 gene (2.2 kb) isolated from YEp13 was
treated with Klenow fragment and inserted between the
HincII/EcoO65I sites internal to the
TRX2 gene in pTR-2, which was also treated with Klenow
fragment, to yield pTRD2. pTRD2 was digested with PstI and
SmaI, and the trx2
::LEU2
fragment was transformed to the yap1
mutant to yield
YT-2a.
Mitochondrial thioredoxin gene, TRX3 (YCR083w), was
also amplified using the following oligonucleotide primers:
5'-GGCGGAGAATAGGGATCCACTGCGA-3' and 5'-GTCTCCGCTGGATCCAGAATATAAC-3'.
The amplicon (1.4 kb) was digested with BamHI and
cloned to the BamHI site of YEp13 (YEpTRX3).
To disrupt the GRX genes, the GRX1 gene was amplified
using the following primers: 5'-CATCCTTAGAAAGGATCCCACATTG-3' and
5'-CGAGACGTACGGGATCCTAAAGTGG-3'. The amplicon (1.1 kb) was digested
with BamHI and cloned to the BamHI site of YEp13
(YEpGRX1), and also to the BamHI site of pUC19 (pGR-1). A
1.2-kb BglII-ClaI fragment containing the
TRP1 gene from pRS414 was inserted between
BglII/ClaI sites internal to the GRX1
gene in pGR-1 (pGRD1). pGRD1 was digested with SmaI and SalI, and the grx1
::TRP1
fragment was transformed to YPH250 to yield the grx1
mutant. The GRX2 gene was also amplified using the following
primers: 5'-GGGTCATTGCCGTGGATCCTACAAAAC-3' and
5'-TACACGTGGATCCTGATGCTGAAGT-3'. The amplicon (1.2 kb) was
digested with BamHI and cloned to the BamHI site
of YEp13 (YEpGRX2), and also to the BamHI site of pUC19 (pGR-2). The URA3 gene (1.2 kb) isolated from YEp24 was
treated with Klenow fragment and inserted between the
BsaAI/BsaAI sites internal to the GRX2
gene (pGRD2). pGRD2 was digested with SmaI and
SacI, and the grx2
::URA3
fragment was transformed to YPH250 and the grx1
to yield
the grx2
mutant and the
grx1
/grx2
mutant, respectively. Disruption
of each gene was verified by polymerase chain reaction. The
trx1
/trx2
mutant showed the methionine
auxotrophy, the increase of cell size, and elongation of generation
time as reported by Muller (35).
Construction of the GSH1-lacZ Fusion Gene--
The
GSH1 promoter fragment containing the region from
800 to
+33 (+1 representing the start of translation) was generated by
polymerase chain reaction using the primers:
5'-TAATCTTATGAATCCCGGGGATTTTATCGG-3' and
5'-CTAGACTCAAACCCGGGCAAAGGCGTGCCC-3'. The amplicon was digested with SmaI and cloned into the SmaI site of
pMC1871 containing the coding region of lacZ (Amersham
Pharmacia Biotech), to yield pMC-GSH1lacZ. As a result of this
construction, the first 11 amino acid residues of Gsh1 were fused to
-galactosidase whose first 8 amino acids were deleted. The
GSH1-lacZ in pMC-GSH1lacZ was isolated by digestion with
SalI and cloned into the SalI site of pRS414
(pRS-GSH1lacZ). A Yap1-dependent lacZ reporter
gene containing three SV40 AP-1 sites and the TATA element of the
CYC1 promoter was kindly gifted by Dr. Kuge (21, 26, 29).
-Galactosidase activity was measured as described by
Miller (36). One unit of the activity was defined as the amount of
enzyme increasing A420 per hour at 30 °C.
Protein was determined by the method of Lowry et al.
(37).
Northern Blotting Analysis--
Northern hybridization was
performed using 25 µg of total cellular RNA isolated from yeast cells
by the method of Schmitt et al. (38). The probes were
generated by random primed labeling of the 0.4-kb
EcoRV-BamHI fragment of GSH1 gene,
0.7-kb PvuII-HincII fragment of TRR1
gene, and 1.1-kb EcoRI-PstI fragment of
ACT1 gene, respectively, with [
-32P]dCTP
using a kit (Random Primer DNA labeling kit version 2, Takara).
GFP-Yap1 Fusion--
pRS cup1 cp-GFP-YAP1 was kindly provided by
Dr. Kuge (26). To visualize DNA, the cells were stained with 1 µg/ml
4',6'-diamidino-2-phenylindole dihydrochloride.
Production of Anti-TRX Antibody--
A
NdeI/BamHI fragment encoding the whole coding
region of the TRX2 gene was inserted into the
NdeI/BamHI site of pET15-b (Novagen) to construct
pET-TRX2. The resulting protein contained six histidine tag residues
fused in-frame with the TRX2 coding region. pET-TRX2 was
transferred into E. coli strain BL21(DE3). Histidine-tagged Trx2 was purified using histidine affinity column chromatography (His-trap, Amersham Pharmacia Biotech), followed by gel filtration chromatography (Superdex 75, Amersham Pharmacia Biotech). Purified fusion protein was then used for the production of anti-yeast TRX
antibody using New Zealand White rabbits. Immunization and purification
of anti-Trx antibody were accomplished by Sawady Technology Co., Ltd.,
Tokyo, Japan. This anti-TRX antibody was specific to yeast TRX and was
able to detect both Trx1 and Trx2.
Immunofluorescence Technique--
Immunofluorescence microscopic
observation of yeast was performed by the methods of Rose et
al. (39). Anti-rabbit IgG (H+L)-fluorescein isothiocyanate
(FI-1000, Vector Laboratory Inc.) was used as the secondary antibody.
Western Blotting Analysis--
Cell extracts were prepared
according to Wemmie et al. (28), and 170 µg of total
protein of each sample was run on 10% SDS-polyacrylamide gels.
Proteins were electrically transferred to polyvinylidene difluoride
membrane (Immobilon, Millipore). Anti-Yap1 antiserum raised in rabbit
was kindly gifted by Dr. Moye-Rowley. Horseradish peroxidase-conjugated
secondary antibody (Jackson Immunoresearch Laboratory, Inc.) and
diaminobenzidine were used to visualize immunoreactive protein.
Glutathione Reductase, Total Glutathione, and
H2O2 Stress Treatment--
The activity of
glutathione reductase, total glutathione, and the susceptibility and
adaptation to H2O2 were determined as described
previously (40, 41).
Measurement of Intracellular Oxidation--
Intracellular
oxidation level of yeast was measured using the oxidant-sensitive probe
2',7'-dichlorofluorescin diacetate (DCFH-DA) purchased from Molecular
Probes (42). Cells growing exponentially in SD medium were collected
and resuspended in fresh SD medium containing 0.1 mM
DCFH-DA and incubated at 30 °C for 20 min. After the incubation,
cells were washed, resuspended in distilled water, and disrupted by
vortexing with glass beads. Cell extracts (70 µl) were mixed in 500 µl of distilled water, and fluorescence was measured with
ex = 490 nm and
em = 524 nm using a
Hitachi F-3000 spectrofluorometer.
Genetic Manipulation of Yeast--
Mating, sporulation,
dissection, and tetrad analysis of yeast were done as described by Rose
et al. (39).
 |
RESULTS |
The TRX-deficient Mutant Shows the Constitutive Activation of
Yap1--
In order to see the effect of TRX and GRX on the activity of
Yap1, we investigated the levels of cellular glutathione and glutathione reductase (GR) activity in the TRX- and GRX-deficient mutants. The GSH1 and GLR1 genes, which are
target genes for Yap1 (19, 20), encode
-glutamylcysteine synthetase
(Gsh1) and GR, respectively (43, 44). The Gsh1 catalyzes the first and rate-limiting step of glutathione synthesis (45). Therefore, it is
conceivable that the levels of intracellular glutathione and GR
activity reflect the activity of Yap1.
Table I shows the levels of total
glutathione and GR activity in various mutants. As reported previously,
the yap1
mutant showed lower levels of total glutathione
and GR activity than the wild type (19, 20). Total glutathione and GR
activity in the wild type were increased by the treatment with 0.2 mM H2O2, but not in the
yap1
mutant (46). The levels of glutathione and GR
activity in trx1
/trx2
were constitutively
high under non-stressed conditions, and the values were higher than
those in the wild type which was treated with
H2O2. This indicates that the loss of both Trx1
and Trx2 affects intracellular glutathione metabolism. GRX deficiency
(grx1
/grx2
) and single-gene mutation of TRX
or GRX genes did not affect total glutathione levels and GR activity
(data for single-gene mutants are not shown), and our results are
consistent with the previous reports (34, 47). The results in Table I
imply that Yap1 is constitutively activated in
trx1
/trx2
even though the cells are not
exposed to oxidative stress.
View this table:
[in this window]
[in a new window]
|
Table I
Cellular total glutathione contents and GR activity in various mutants
Cells growing exponentially were treated with or without 0.2 mM H2O2 for 60 min. Data are means ± S.D. from three independent experiments. One unit of GR was defined as
the amount of enzyme reducing 1.0 µmol of GSSG/min at 25 °C.
|
|
To confirm the constitutive activation of Yap1 in the TRX-deficient
mutant, we next assessed the expression of the lacZ reporter gene under the control of the GSH1 promoter. A fusion gene
was constructed containing the lacZ coding region fused to
the GSH1 promoter sequence which contains the Yap1 binding
site (5'-TTAGTCA-3') (19). As shown in Fig.
1A,
-galactosidase activity
was increased with H2O2 treatment in the wild
type, but not in the yap1
, as reported previously (48).
The
-galactosidase activities in single mutants (trx1
or trx2
) under non-stressed conditions were the same to
that in the wild type. On the contrary, the basal level of
-galactosidase activity in trx1
/trx2
was
significantly higher than that of the wild type, and the value was
almost the same as that of the wild type treated with 0.2 mM H2O2 (the wild type with
H2O2, 88.8 ± 1.3;
trx1
/trx2
without
H2O2, 95.1 ± 1.2 units/mg). The
-galactosidase activity in trx1
/trx2
was
scarcely increased by the treatment with H2O2,
suggesting that Yap1 activity was constitutively high and presumably
saturated in the trx1
/trx2
mutant under
non-stressed conditions.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of the TRX deficiency on the
expression of Yap1 target genes. Cells at exponential phase were
harvested, resuspended in fresh SD medium, and treated with or without
0.2 mM H2O2 for 60 min. Cell
extracts were prepared and -galactosidase activity was assayed
(A and D). Data are means ± S.D. from three
independent experiments. A, expression level of the
GSH1-lacZ reporter gene. B and C,
Cells were treated with or without 0.2 mM
H2O2 for 30 min. Total cellular RNA was
prepared, and 25 µg of RNA was applied to each slot. D,
expression level of the lacZ reporter gene containing
AP-1-binding site followed by TATA box of the CYC1
gene.
|
|
We reconfirmed the increased expression of the GSH1 gene in
trx1
/trx2
by Northern blotting analysis
(Fig. 1B). Basal level of the GSH1 gene
expression in trx1
/trx2
was almost the same as that of the H2O2-treated wild type.
Expression of the GSH1 gene in
trx1
/trx2
did not increase with 0.2 mM H2O2 stress. These results were
in good agreement with those obtained by using the GSH1-lacZ
reporter gene assay. Expression of the TRR1 gene, another
target gene for Yap1 (22), was also constitutively high in
trx1
/trx2
, but not in
grx1
/grx2
(Fig. 1C).
In yeast and other eukaryotic cells, expression of most genes is
controlled by multiple transcription factors acting co-operatively (49). To see whether other factor(s) that may bind to the
GSH1 promoter region are involved in increased expression of
the GSH1-lacZ reporter gene in the
trx1
/trx2
mutant, we also examined the expression of a lacZ reporter gene driven by three SV40 AP-1
sites and the TATA element of the CYC1 promoter (21, 26,
29). This reporter gene was proven to be solely regulated by Yap1 (21, 26, 29). Expression of the Yap1-dependent lacZ
reporter gene was also constitutively induced in
trx1
/trx2
(Fig. 1D), as well as
the GSH1-lacZ fusion. This suggests that Yap1 is the main
factor for the increased expression of Yap1 target genes in the
trx1
/trx2
mutant. These experiments showed
that the deficiency of TRX (trx1
/trx2
) resulted in constitutive acceleration of the expression of Yap1 target
genes even under non-stressed conditions.
Yap1 Is Constitutively Localized in the Nucleus in
trx1
/trx2
--
To determine whether constitutive high expression
of Yap1 target genes is caused by the increase of Yap1 protein or not,
we compared the amounts of Yap1 in the wild type and
trx1
/trx2
under non-stressed conditions by
Western blotting analysis. The Yap1-specific bands were detected at
similar intensities both in the wild type and the
trx1
/trx2
mutant (Fig.
2). With the consideration of previous
reports that the levels of Yap1 do not change during oxidative stress
(27, 28), the constitutive high activity of Yap1 in
trx1
/trx2
under non-stressed conditions can
be attributed to a post-translational modification of Yap1, where TRX
is likely to be involved.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
The levels of Yap1 protein are unaffected by
the TRX deficiency. Cells were cultured until exponential phase
without stress treatment, and cell extracts were prepared. An equal
amount of protein (170 µg) from the wild type,
trx1 /trx2 , and yap1 was
subjected to SDS-PAGE (10% polyacrylamide gel). Western blotting
analysis was carried out using anti-Yap1 antiserum. Lane 1,
wild type; lane 2,
trx1 /trx2 ; lane 3,
yap1 .
|
|
It is reported that the Yap1 activity is regulated at the level of its
localization. Yap1 exists both in the cytoplasm and in the nucleus
under non-stressed conditions, while it is concentrated in the nucleus
by oxidative stress (26). We reconfirmed this by using the GFP-Yap1
fusion in the wild type (Fig. 3). In a
single mutant of trx1
or trx2
, Yap1 behaved
similarly to that in the wild type (data not shown). On the other hand,
Yap1 was constitutively localized in the nucleus in
trx1
/trx2
not only under oxidative-stressed conditions but also under non-stressed conditions. Highly constitutive expression of the Yap1 target genes in
trx1
/trx2
was most likely caused by the
constitutive localization of Yap1 in the nucleus.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3.
Yap1 is constitutively localized in the
nucleus in the trx1 /trx2
mutant. GFP fluorescence was visualized in living
yeast cells carrying pRS cp-GFP-YAP1 (25). Cells at exponential phase
were harvested, resuspended in fresh SD medium, and treated with or
without 0.2 mM H2O2. Cells were
stained with 1 µg/ml 4',6'-diamidino-2-phenylindole dihydrochloride
(DAPI) to visualize DNA.
|
|
High Activity of Yap1 in trx1
/trx2
Was Repressed under
Anaerobic Conditions--
It has been reported that cysteine residues
are important in the redox-regulation of AP-1, NF-
B, and OxyR (2,
3). Yap1 also contains a CRD at the C terminus, and it was reported
that cysteine residue(s) within the CRD is necessary to mediate the response to oxidative stress (26-28, 30). Thus, Yap1 also might be
regulated via the redox modification of cysteine residue(s) and TRX may
participate in this redox-regulation. To assess this, we investigated
the activity of Yap1 in the trx1
/trx2
mutant under anaerobic conditions.
-Galactosidase activity derived
from GSH1-lacZ in the wild type was virtually the same under
both anaerobic and aerobic conditions without oxidative stress. On the
other hand,
-galactosidase activity in
trx1
/trx2
was markedly repressed under
anaerobic conditions to the level similar to the wild type (Fig.
4A). Furthermore, this
repression was restored by the transfer of the cells to the aerobic
conditions. Similar results were observed using the
Yap1-dependent lacZ reporter gene (Fig.
4B). These results strongly suggest that redox states in the
cells reflect the activity of Yap1 in
trx1
/trx2
.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
The activity of Yap1 is repressed under
anaerobic conditions in
trx1 /trx2 .
A and B, wild type and
trx1 /trx2 cells were cultured until
exponential phase without shaking under anaerobic conditions. Cells
were then harvested and resuspended in fresh SD medium and incubated
with shaking under aerobic conditions for another 3 or 6 h at
30 °C. Cell extracts were prepared, and -galactosidase activity
was assayed as described under "Experimental Procedures." For
control experiments, cells were grown with shaking under aerobic
conditions. A, expression of the GSH1-lacZ
reporter gene. B, expression level of the lacZ
reporter gene containing AP-1-binding site followed by TATA box of the
CYC1 gene. Yeast strains were as follows: empty bar, wild type; filled bar,
trx1 /trx2 . C, cells
at exponential phase were harvested and resuspended in fresh SD medium
containing 0.1 mM DCFH-DA for 20 min at 30 °C, and then
cell extracts were prepared. Fluorescence intensity was measured with
ex = 490 nm and em = 524 nm. Fluorescence
intensity of the wild type are relatively taken as 100. Data are
means ± S.D. from three independent experiments.
|
|
Additionally, we measured the levels of intracellular oxidation in
trx1
/trx2
using the oxidant-sensitive probe
DCFH-DA. The level of intracellular oxidation in
trx1
/trx2
was more than 2-fold higher than
that in the wild type, while that in
grx1
/grx2
was only 1.1-fold higher (Fig.
4C). These results indicate that the intracellular
environments of trx1
/trx2
were in more
oxidized states than those of the wild type. Redox states of the
intracellular environments and the redox regulation of transcription
factors are suggested to be well linked (3, 13). Thus, the oxidative environments in trx1
/trx2
may also account
for the constitutive activation of Yap1.
GRX Does Not Substitute for TRX--
The constitutive activation
of Yap1 was observed only in the TRX-deficient mutant
(trx1
/trx2
), but not in the GRX-deficient mutant (grx1
/grx2
). However, in E. coli, the thioredoxin system and the glutaredoxin system can
partially substitute for each other in vivo (11, 12).
Overexpression of the grxA gene in a trxA mutant
can substitute for thioredoxin 1 in E. coli (50). We
examined whether or not the overexpression of GRX gene in
trx1
/trx2
can repress the constitutive
activation of Yap1. The Yap1 activity in
trx1
/trx2
was reduced to the basal level of
the wild type by overexpression of either the TRX1 or
TRX2 gene alone, i.e. the levels of total
glutathione, GR activity, and the expression of GSH1-lacZ
were reduced to those of the wild type (Fig.
5; data of total glutathione and GR
activity are not shown). On the other hand, overexpression of the
GRX1 or GRX2 gene did not affect the Yap1
activity in trx1
/trx2
. Therefore, GRX was
thought to be unable to substitute for TRX in the regulation of Yap1
activity in vivo. Overexpression of the TRX3 gene
encoding mitochondrial TRX also did not affect the Yap1 activity in
trx1
/trx2
, suggesting the difference of
functions between cytosolic TRX and mitochondrial TRX.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
GRX does not affect the activity of
Yap1. Cells of the trx1 /trx2 mutant
carrying YEp13-based plasmids (YEpTRX1, YEpTRX2, YEpTRX3, YEpGRX1,
YEpGRX2) were cultured until exponential phase, and treated with or
without 0.2 mM H2O2 for 60 min.
Cell extracts were prepared and -galactosidase activity
(GSH1-lacZ) was assayed as described under "Experimental
Procedures." Data are means ± S.D. from three independent
experiments.
|
|
Interaction between TRX and Yap1--
The constitutive activation
of Yap1 in trx1
/trx2
suggests that TRX may
regulate the Yap1 activity negatively. To see whether TRX associates
with Yap1 directly or not, we first investigated the intracellular
localization of TRX by immunofluorescence microscopy using anti-TRX
antibody. If TRX interacts with Yap1 directly to repress the Yap1
activity, the intracellular localization of TRX is expected to be
similar to that of Yap1. Yeast TRX would be able to enter or leave the
nucleus by diffusion through the nuclear pore complex on account of its
molecular size (molecular masses of both Trx1 and Trx2 are
approximately 11 kDa) (51). TRX was observed predominantly in the
cytoplasm under non-stressed conditions (Fig.
6). After the treatment of the wild type
cells with a mild oxidative stress (0.2 mM
H2O2), TRX was observed both in the cytoplasm and in the nucleus, suggesting the possibility that TRX can associate with Yap1 both in the nucleus and in the cytoplasm. The increase of the
levels of TRX protein by H2O2 (0.2 mM) treatment was also confirmed by Western blotting
analysis (data not shown). In the case of HeLa cells, TRX is
translocated from the cytoplasm to the nucleus after the stress
treatment and concentrated in the nucleus for a long time (10).
In S. cerevisiae, however, the concentration of TRX in the
nucleus was not observed under oxidative conditions.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
The intracellular localization of TRX.
The intracellular localization of TRX was observed by
immunofluorescence using the anti-yeast TRX antibody. The wild type
cells in the exponential phase were treated with or without 0.2 mM H2O2 for 30 min. The increase of
the level of TRX protein by H2O2 (0.2 mM) was also observed by Western blotting using this
antibody (data not shown).
|
|
Next, we performed two-hybrid assay experiments to examine the direct
association of Yap1 with Trx1 or Trx2 (Matchmaker Two-Hybrid System 2, CLONTECH). However, we could not detect the direct
association between Yap1 and Trx1 or Trx2. This might be because their
association is too weak to detect by this assay system, or because TRX
associates with Yap1 via other factors, such as Ref-1 in the case of
AP-1 regulation (10).
Synthetic Lethality of yap1 Null Allele and
trx1
/trx2
--
Because the expression of the Yap1 target genes
are enhanced in the trx1
/trx2
mutant, which
resulted in the increase of the activity of antioxidant enzymes, we
suspected that the trx1
/trx2
mutant might
acquire the tolerance to oxidative stress. We investigated the
susceptibility to H2O2 (0.2-5 mM)
and the induction of adaptation to H2O2 stress
in trx1
/trx2
. The
trx1
/trx2
mutant showed great susceptibilities to H2O2 despite the increase
of glutathione and antioxidant enzymes (Fig.
7A). Furthermore, the
trx1
/trx2
mutant was unable to induce the
adaptation to H2O2 despite of the constitutive activation of Yap1 (Fig. 7B). The wild type induced a large
increase in tolerance to 2 mM H2O2
by pretreatment with a sublethal dose of H2O2
(0.2 mM, 60 min), while the
trx1
/trx2
mutant did not. These results
indicate that the constitutive activation of Yap1 may be essential for
the trx1
/trx2
mutant to survive under
aerobic conditions rather than to acquire the resistance against
oxidative stress.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 7.
The
trx1 /trx2
mutant is hypersensitive to
H2O2 despite the constitutive activation of
Yap1. A, cells growing exponentially in SD medium at
30 °C were harvested and resuspended in 100 mM potassium
phosphate buffer, pH 7.4, and treated with various concentrations of
H2O2. Cells were withdrawn periodically,
diluted with 100 mM potassium phosphate buffer and plated
on YPD agar plates to monitor the cell viability.
H2O2 concentrations were: 0 ( ), 0.2 ( ), 1 ( ), 2 ( ), and 5 ( ) mM, respectively. B,
cells growing exponentially in SD medium at 30 °C were harvested.
, cells were pretreated with 0.2 mM
H2O2 in fresh SD medium for 60 min, and then
challenged to 2 mM H2O2. , cells
were challenged directly to 2 mM
H2O2. Results represent the mean from three
independent experiments.
|
|
In this study, we tried to construct a
yap1
/trx1
/trx2
triple mutant
to see the genetic interaction of these genes. We tried several times
to disrupt the TRX1 gene in YT-2a (MATa
yap1
::HIS3 TRX1
trx2
::LEU2), but no viable
transformant was obtained. In contrast, it was possible to construct
the yap1
/grx1
/grx2
mutant. To
confirm the lethality of this triple mutant
(yap1
/trx1
/trx2
), we
constructed a diploid strain YT-21
(MATa/MAT
yap1
::HIS3/yap1
::HIS3 TRX1/trx1
::URA3
trx2
::LEU2/TRX2) for tetrad analysis, by
crossing YT-1
(MAT
yap1
::HIS3
trx1
::URA3 TRX2) and YT-2a. Thirty-seven asci were subjected to tetrad analysis and all spores (37 × 4 = 148) were incubated on YPD plates at 30 °C for 2 days.
Thirty-eight spores among 148 spores did not germinate. The genotype of
each germinated strain (148
38 = 110 strains) was analyzed
to determine the genotypes of the 38 spores that did not germinate. The
TRX1-TRX2 ascus type showed random assortment (parental
ditype:nonparental ditype:tetratype was 6:7:24, or approximately
1:1:4). This result seems reasonable because the TRX1 and
TRX2 genes locate on the different chromosomes
(TRX1 on chromosome XII and TRX2 on chromosome VII). The genotypes of all 38 spores were inferred to be triple mutant
(yap1
/trx1
/trx2
).
Therefore, we concluded that the combination of the yap1
mutation with the trx1
/trx2
mutation was
lethal at least under aerobic conditions. This result also strongly
indicates that the constitutive activation of Yap1 is essential for the trx1
/trx2
mutant to survive under aerobic conditions.
 |
DISCUSSION |
TRX in the Regulation of Yap1--
In this study, we demonstrated
that Yap1 is constitutively activated and concentrated in the nucleus
in trx1
/trx2
under non-stressed conditions.
No difference was observed in the levels of Yap1 protein between the
wild type and trx1
/trx2
, indicating that
the constitutive activation of Yap1 was due to its post-translational modification. Additionally, we also indicated the possibility that TRX
negatively controls the activity of Yap1 via redox states because the
constitutive activation was observed only under aerobic conditions.
It was clarified that the localization of Yap1 (and the activity of
Yap1) is regulated by the nuclear export of Yap1 mediated by the
interaction between Crm1 and the NES within the CRD of Yap1, and that
the cysteine residue(s) within the CRD serve as redox sensors which
regulate this nuclear export (29, 30). It is conceivable that TRX
affects the redox states of cysteine residue(s) within the CRD, because
TRX is a reductant of disulfide bonds. TRX may reduce the cysteine
residue(s) to keep the CRD in a form which is able to interact with
Crm1. Therefore, Yap1 was constitutively concentrated in the nucleus in
trx1
/trx2
, but not concentrated in the
nucleus under normal conditions in the cells that contain TRX (Fig.
3).
It is still controversial whether TRX directly associates with cysteine
residue(s) of the CRD or not. We confirmed that TRX exists not only in
the cytoplasm but also in the nucleus, especially after the treatment
with a mild oxidative stress (Fig. 6). Therefore, TRX would be possible
to associate with Yap1 both in the cytoplasm and in the nucleus.
However, we were not able to detect the direct interaction of Yap1 with
Trx1 or Trx2 by the two-hybrid assay experiments. This might be because
their association is too weak to detect by this assay system, or
because TRX cannot associate directly with Yap1. If TRX has no direct
association with Yap1, TRX may affect the redox states of the CRD via
other factors, such as Ref-1 in the case of AP-1 regulation (10). Yan
et al. (30) reported that a single cysteine residue within
the CRD is necessary and sufficient for the response to oxidative
stress, and speculated that the cysteine residue(s) within the CRD form linkages with a third protein, as yet unidentified, which serves to
mask the NES. TRX may regulate the formation of these linkages. Interestingly, the TRX2 gene is one of the target genes for
Yap1. Therefore, Yap1 may be autoregulated; active form of Yap1
enhances transcription of the TRX2 gene, and Trx2 may
promote the interaction between Crm1 and Yap1 by unmasking the NES to
export Yap1, as one of the down-regulations. This idea may
be supported by the result that TRX exists in the nucleus after the
treatment with a mild oxidative stress (Fig. 6).
Another possible explanation is that TRX may take part in the
regulation of Yap1 via the redox states of the whole intracellular environments. TRX not only modifies proteins such as transcription factors, it also maintains intracellular environments in reduced states
(11, 12). The deficiency of the thioredoxin system causes the oxidation
of the cytoplasm in E. coli (12). The TRX deficiency in
yeast may change the intracellular redox states, and consequently this
change would cause the redox modification of cysteine residues of the
CRD and the activation of Yap1. Indeed, we showed that the level of
intracellular oxidation in trx1
/trx2
was
higher than that of the wild type (Fig. 4C), and it has been reported that the trx1
/trx2
mutant
accumulates high levels of oxidized glutathione (47). These results
support the possibility of the change in intracellular redox states
caused by TRX deficiency in S. cerevisiae.
Taking these results together with the results in this study, we
present a tentative model for the roles of TRX in the regulation of
Yap1. Under normal conditions, TRX reduces intracellular environments and may maintain the CRD in a reduced form, which can interact with
Crm1. After the stimulation with a mild oxidative stress, the synthesis
of TRX is induced by the activated Yap1, and then TRX may function as a
deactivator for Yap1 in the nucleus besides as an antioxidant enzyme.
TRX may unmask the NES and facilitate the interaction between the CRD
and Crm1. TRX in the regulation of Yap1 in yeast may play a similar
role of GRX in the deactivation of OxyR in E. coli (3). The
details of the interaction between Yap1 and TRX are currently under investigation.
The Difference in Functions between TRX and GRX--
In addition
to TRX, GRX is also a reductant of disulfide bonds, and known as a
redox regulator of OxyR in E. coli (3). It has been reported
that both TRX and GRX can partially substitute for each other in
vivo, and contribute to maintaining the cytoplasm in a reduced
state in E. coli (12, 50). Both of these thiol-disulfide oxidoreductases are required for protection against oxidative stress in
S. cerevisiae (21, 34). However, GRX seems to be not
involved in the regulation of Yap1 because GRX deficiency did not
affect the activity of Yap1 (Table I and Fig. 1C) and the
constitutive activation of Yap1 in
trx1
/trx2
was not repressed by the
overexpression of the GRX1 or GRX2 gene (Fig. 5).
Additionally, the
yap1
/grx1
/grx2
triple mutant
was viable but the
yap1
/trx1
/trx2
triple mutant
showed synthetic lethality. There may be a distinct difference between
TRX and GRX in their functions regarding the regulation of Yap1
activity. Differences were also observed in other cellular metabolism,
i.e. the level of intracellular oxidation of the
trx1
/trx2
mutant was higher than that of
the grx1
/grx2
mutant (Fig. 4C),
and grx
/grx2
mutant did not show the
methionine auxotrophy and the increase of cell size. In E. coli, there is difference in the substrate specificity between TRX
and GRX (50). TRX may be playing irreplaceable role(s) and be more
important than GRX as an antioxidant enzyme in S. cerevisiae. The difference in redox potential may be one of causes
of the difference in functions between TRX and GRX (52), but it is
still obscure what the cause of the difference in functions is.
Synthetic Lethality of yap1
and trx1
/trx2
--
Another
important phenotype to be noted in the relationship between Yap1 and
TRX is the synthetic lethality of yap1 null mutation and TRX
deficiency (trx1
/trx2
). The synthetic
lethality of the yap1
/trx1
/trx2
triple
mutation strongly indicates that Yap1 is essential in
trx1
/trx2
for the growth under aerobic
conditions. As we demonstrated here, the levels of transcription of the
genes encoding antioxidant enzymes, such as GSH1,
GLR1, and TRR1 (whose expressions are under the
control of Yap1), were increased in trx1
/trx2
(Fig. 1 and Table I). Such an
increase of antioxidant enzymes must have some physiological effect(s)
that allow the trx1
/trx2
mutant to survive
under aerobic conditions. The simplest explanation would be that the
constitutive activation of Yap1 is essential for
trx1
/trx2
to compensate for TRX deficiency. The trx1
/trx2
mutant may barely survive by
increasing other antioxidant enzymes in the Yap1-dependent
manner to keep the level of intracellular oxidation as low as possible.
Thus, despite the constitutive activation of Yap1, the
trx1
/trx2
mutant was hypersensitive to
H2O2 (Fig. 7) and its intracellular oxidation
level was still higher than that of the wild type (Fig. 4C).
The synthetic lethality of
yap1
/trx1
/trx2
presumably
reflects the more oxidized states of intracellular environments. The
intracellular oxidation level of grx1
/grx2
was almost the same with that of the wild type (Fig.
4C), and the
yap1
/grx1
/grx2
triple mutant
was viable. The disruption of the GLR1 gene was also lethal
in the trx1
/trx2
background under aerobic
conditions (47). These observations may support our idea.
 |
ACKNOWLEDGEMENTS |
We are grateful to Drs. S. Kuge and N. Jones
for providing the trx2::HIS3 plasmid,
pRS cup1 cp-GFP-YAP1, and a Yap1-dependent lacZ
reporter gene, and Dr. W. S. Moye-Rowley for providing the anti-Yap1 antiserum and pSM27. We thank K. Fukuda for assistance in
tetrad analysis.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 81-774-38-3771;
Fax: 81-774-33-3004; E-mail: inoue@food2.food.kyoto-u.ac.jp.
 |
ABBREVIATIONS |
The abbreviations used are:
TRX, thioredoxin;
GRX, glutaredoxin;
GR, glutathione reductase;
GFP, green fluorescent
protein;
CRD, cysteine-rich domain;
NES, nuclear export sequence;
DCFH-DA, 2',7'-dichlorofluorescin diacetate;
kb, kilobase(s).
 |
REFERENCES |
| 1.
|
Jamieson, D. J.,
and Storz, G.
(1997)
in
Oxidative Stress and The Molecular Biology of Antioxidant Defenses
(Scandalios, J. G., ed)
, pp. 91-116, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 2.
|
Nakamura, H.,
Nakamura, K.,
and Yodoi, J.
(1997)
Annu. Rev. Immunol.
15,
351-369[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Zheng, M.,
Åslund, F.,
and Storz, G.
(1998)
Science
279,
1718-1721[Abstract/Free Full Text]
|
| 4.
|
Matthews, J. R.,
Wakasugi, N.,
Virelizier, J.-L.,
Yodoi, J.,
and Hay, R. T.
(1992)
Nucleic Acids Res.
20,
3821-3830[Abstract/Free Full Text]
|
| 5.
|
Hayashi, T.,
Ueno, Y.,
and Okamoto, T.
(1993)
J. Biol. Chem.
268,
11380-11388[Abstract/Free Full Text]
|
| 6.
|
Qin, J.,
Clore, G. M.,
Kennedy, W. M. P.,
Huth, J. R.,
and Gronenborn, A. M.
(1995)
Structure
3,
289-297[Medline]
[Order article via Infotrieve]
|
| 7.
|
Walker, L. J.,
Robson, C. N.,
Black, E.,
Gillespie, D.,
and Hickson, I. D.
(1993)
Mol. Cell. Biol.
13,
5370-5376[Abstract/Free Full Text]
|
| 8.
|
Xanthoudakis, S.,
Miao, G. G.,
and Curran, T.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
23-27[Abstract/Free Full Text]
|
| 9.
|
Qin, J.,
Clore, G. M.,
Kennedy, W. P.,
Kuszewski, J.,
and Gronenborn, A. M.
(1996)
Structure
4,
613-620[Medline]
[Order article via Infotrieve]
|
| 10.
|
Hirota, K.,
Matsui, M.,
Iwata, S.,
Nishiyama, A.,
Mori, K.,
and Yodoi, J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3633-3638[Abstract/Free Full Text]
|
| 11.
|
Åslund, F.,
Berndt, K. D.,
and Holmgren, A.
(1997)
J. Biol. Chem.
272,
30780-30786[Abstract/Free Full Text]
|
| 12.
|
Prinz, W. A.,
Åslund, F.,
Holmgren, A.,
and Beckwith, J.
(1997)
J. Biol. Chem.
272,
15661-15667[Abstract/Free Full Text]
|
| 13.
|
Demple, B.
(1998)
Science
279,
1655-1656[Free Full Text]
|
| 14.
|
Hertle, K.,
Haase, E.,
and Brendel, M.
(1991)
Curr. Genet.
19,
429-433[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Hussain, M.,
and Lenard, J.
(1991)
Gene (Amst.)
101,
149-152[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Schnell, N.,
and Entian, K.-D.
(1991)
Eur. J. Biochem.
200,
487-493[Medline]
[Order article via Infotrieve]
|
| 17.
|
Wu, A.,
Wemmie, J. A.,
Edgington, N. P.,
Goebl, M.,
Guevara, J. L.,
and Moye-Rowley, W. S.
(1993)
J. Biol. Chem.
268,
18850-18858[Abstract/Free Full Text]
|
| 18.
|
Hirata, D.,
Yano, K.,
and Miyakawa, T.
(1994)
Mol. Gen. Genet.
242,
250-256[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Wu, A.-L.,
and Moye-Rowley, W. S.
(1994)
Mol. Cell. Biol.
14,
5832-5839[Abstract/Free Full Text]
|
| 20.
|
Grant, C. M.,
Collinson, L. P.,
Roe, J.-H.,
and Dawes, I. W.
(1996)
Mol. Microbiol.
21,
171-179[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Kuge, S.,
and Jones, N.
(1994)
EMBO J.
13,
655-664[Medline]
[Order article via Infotrieve]
|
| 22.
|
Morgan, B. A.,
Banks, G. R.,
Toone, W. M.,
Raitt, D.,
Kuge, S.,
and Johnston, L. H.
(1997)
EMBO J.
16,
1035-1044[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Moye-Rowley, W. S.,
Harshman, K. D.,
and Parker, C. S.
(1989)
Genes Dev.
3,
283-292[Abstract/Free Full Text]
|
| 24.
|
Wemmie, J. A.,
Szczypka, M. S.,
Thiele, D. J.,
and Moye-Rowley, W. S.
(1994)
J. Biol. Chem.
269,
32592-32597[Abstract/Free Full Text]
|
| 25.
|
Alarco, A.-M.,
Balan, I.,
Talibi, D.,
Mainville, N.,
and Raymond, M.
(1997)
J. Biol. Chem.
272,
19304-19313[Abstract/Free Full Text]
|
| 26.
|
Kuge, S.,
Jones, N.,
and Nomoto, A.
(1997)
EMBO J.
16,
1710-1720[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Takeuchi, T.,
Miyahara, K.,
Hirata, D.,
and Miyakawa, T.
(1997)
FEBS Lett.
416,
339-343 |